MLCi2 multileaf collimator
Elekta’s MLCi2 multileaf collimator helps achieve a fine balance between the delivery of high doses to the target and reduced dose to healthy tissues outside of the target volume. MLCi2, which provides low integral dose even when using advanced delivery techniques, is driven by Elekta’s fully integrated digital control system.
Unlike non-digital systems, there is no lag in the transmission of information, ensuring continuous verification and accurate placement of all leaves. This allows faster, safer and more accurate delivery than non-digital systems.
ELEKTA MLCI2中的主动泄漏减少机构，在两个方向上使用隔膜来自动跟踪拖曳叶，从而减少传输。该特征在减少对患者的整体剂量并因此降低诱导的继发性癌症的风险来发挥有价值的作用。bob体育网赌
- High dose conformance
- Active leakage reduction
- Accurate leaf positioning
- 动态运动
- Ability to interdigitate
- Seamless large field delivery
Additional Resources
Treatment delivery systems
With a comprehensive choice of delivery systems, Elekta is the ideal partner for ensuring that each clinic and patient receives the best system and treatment for their needs. Learn more about our solutions below and how they can expand your clinical practice.
Treatment solutions
At the forefront of clinical advancements, Elekta has been instrumental in delivering techniques like IGRT, IMRT, VMAT as well as SBRT and SRT. These techniques have given clinicians the flexibility to deliver conventional therapies to treat a wide range of tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision.